The Journal of Practical Medicine >

2024 , Vol. 40 >Issue 1: 25 - 31

DOI: https://doi.org/10.3969/j.issn.1006-5725.2024.01.005

Feature Reports：Lung cancer

Effect of the KLF14⁃mediated JAK⁃STAT signaling pathway on prognosis of lung cancer

  • Peng WANG ,
  • Sumei YAO ,
  • Xuedong LV ,
  • Jinliang. CHEN
Expand
  • Department of Respiratory，Nantong First People's Hospital，Nantong 226000，China

Received date: 2023-07-26

  Online published: 2024-01-24

Fold

Abstract

Objective To investigate the influence of the Janus kinase?signal transducer and transcription activator （JAK?STAT） signaling pathway mediated by Kruppel?like factor 14 （KLF14） on the prognosis of non?small cell lung cancer （NSCLC）. Methods From January 2018 to September 2019， NSCLC tissues from 80 patients and malignancy?free paracancerous tissues from 25 patients were collected. Medical follow?up ended in April 2023. Immunohistochemistry was used to detect the expression of KLF14 in tissues， and the patients were divided into a high?expression group and a low?expression group according to the median level of KLF14 expression. Over?expression or knock?down of KLF14 and JAK1 was achieved by transfection of KLF14 and JAK1 overexpression plasmid in A549 cells and transfection of KLF14 and JAK1 specific short hairpin RNA （shKLF14 and shJAK1） in HCC827 cells. The proliferation activity of cells was analyzed by cell clone formation test. Transwell analyzed the migration and invasion of cells. Results As compared with the normal paracancerous tissues， the expression of KLF14 in NSCLC tissue decreased （P < 0.001）. The low expression of KLF14 was significantly correlated with tumor diameter of > 3 cm， lymph node metastasis and clinical stage Ⅲ （P < 0.05）. There was a significant difference in the overall survival rate between the high KLF14 expression group and the low KLF14 expression group， and the patients with low KLF14 expression had poor prognosis （P = 0.039）. After overexpression of KLF14， the proliferation ability of A549 cells and the number of migration and invasion of these cells decreased significantly （P < 0.05）； while after knock?down of KLF14， the proliferation ability of HCC827 cells and the number of migration， and invasion of these cells increased significantly （P < 0.05）. As compared with Vector + KLF14 group， the number of colonies， migration and invasion of A549 cells in JAK1 + KLF14 group increased significantly （P < 0.05）. As compared with shNC + shKLF14 group， the number of colonies， migration and invasion of HCC827 cells in shJAK1 + shKLF14 group decreased significantly （P < 0.05）. Conclusions Low expression of KLF14 is associated with poor overall survival in NSCLC patients. Up?regulation of KLF14 significantly inhibits the proliferation and metastasis of lung cancer cells in vitro， and its mechanism may be related to inhibition of the JAK?STAT signaling pathway.

Key words： kruppel?like factor 14; janus kinase?signal transducer and transcriptional activator; non?small cell lung cancer; prognosis

Cite this article

Peng WANG , Sumei YAO , Xuedong LV , Jinliang. CHEN . Effect of the KLF14⁃mediated JAK⁃STAT signaling pathway on prognosis of lung cancer[J]. The Journal of Practical Medicine, 2024 , 40(1) : 25 -31 . DOI: 10.3969/j.issn.1006-5725.2024.01.005

References

1 XIA C， DONG X， LI H， et al. Cancer statistics in China and United States， 2022： profiles， trends， and determinants［J］. Chin Med J， 2022， 135（5）： 584-590.
2 CHEN P， LIU Y， WEN Y， et al. Non-small cell lung cancer in China［J］. Cancer Commun， 2022， 42（10）： 937-970.
3 WANG H， LI C， YANG R， et al. Prognostic value of the geriatric nutritional risk index in non-small cell lung cancer patients： a systematic review and meta-analysis［J］. Front Oncol， 2022， 11： 794862.
4 LI Z Y， ZHU Y X， CHEN J R， et al. The role of KLF transcription factor in the regulation of cancer progression［J］. Biomed Pharmacother， 2023， 162： 114661.
5 SUN W， HU S， ZU Y， et al. KLF3 is a crucial regulator of metastasis by controlling STAT3 expression in lung cancer［J］. Mol Carcinog， 2019， 58（11）： 1933-1945.
6 CHEN X， SHI W， ZHANG H. The role of KLF14 in multiple disease processes［J］. BioFactors， 2020， 46（2）： 276-282.
7 CHEN X Z， HE W X， LUO R G， et al. KLF14/miR-1283/TFAP2C axis inhibits HER2-positive breast cancer progression via declining tumor cell proliferation［J］. Mol Carcinog， 2023， 62（4）： 532-545.
8 ZAHRA K， SHABBIR M， BADSHAH Y， et al. Determining KLF14 tertiary structure and diagnostic significance in brain cancer progression［J］. Sci Rep， 2022， 12（1）： 8039.
9 LIAO W， COUPLAND C A C， BURCHARDT J， et al. Predicting the future risk of lung cancer： development， and internal and external validation of the CanPredict （lung） model in 19· 67 million people and evaluation of model performance against seven other risk prediction models［J］. Lancet Respir Med， 2023， 11（8）：685-697.
10 LYU X， DING X， YE H， et al. KLF14 targets ITGB1 to inhibit the progression of cervical cancer via the PI3K/AKT signalling pathway［J］. Discov Oncol， 2022， 13（1）： 30.
11 MIR R， SAEEDI N H， JALAL M M， et al. Clinical Implications of Krüpple-like Transcription Factor KLF-14 and Certain Micro-RNA （miR-27a， miR-196a2， miR-423） Gene Variations as a Risk Factor in the Genetic Predisposition to PCOS［J］. J Pers Med， 2022， 12（4）： 586.
12 ALZAHRANI O R， MIR R， ALATWI H E， et al. Potential impact of PI3K-AKT signaling pathway genes， KLF-14， MDM4， miRNAs 27a， miRNA-196a genetic alterations in the predisposition and progression of breast cancer patients［J］. Cancers， 2023， 15（4）： 1281.
13 任志磊， 杨崇哲， 银孟卓， 等. 大鼠Kruppel样因子14腺病毒载体的构建及其对心肌细胞肥大的影响［J］. 实用医学杂志， 2021， 37（4）： 441-445.
14 CHU J， HU X C， LI C C， et al. KLF14 alleviated breast cancer invasion and M2 macrophages polarization through modulating SOCS3/RhoA/Rock/Stat3 signaling［J］. Cell Signal， 2022， 92： 110242.
15 CHEN X， SHI W， ZHANG H. The role of KLF14 in multiple disease processes［J］. BioFactors， 2020， 46（2）： 276-282.
16 LV L， YANG N， CAO Y， et al. D-Carvone inhibits the JAK/STAT3 signaling pathway and induced the apoptotic cell death in the human gastric cancer AGS cells［J］. J Biochem Mol Toxicol， 2021， 35（5）： e22746.
17 LIU X， ZHAO D. CKS1B promotes the progression of hepatocellular carcinoma by activating JAK/STAT3 signal pathway［J］. Anim Cells Syst， 2021， 25（4）： 227-234.
18 李晨， 李晓媚， 刘亭， 等. 高盐饮食激活肠JAK1/STAT3通路诱导肠上皮屏障功能障碍［J］.实用医学杂志， 2021， 37（1）： 35-40.
19 AHMAD A， TIWARI R K， ALMELEEBIA T M， et al. Swertia chirayita suppresses the growth of non-small cell lung cancer A549 cells and concomitantly induces apoptosis via downregulation of JAK1/STAT3 pathway［J］. Saudi J Biol Sci， 2021， 28（11）： 6279-6288.
20 MENG J， ZHANG C， ZHU N， et al. EPN3 plays oncogenic role in non-small cell lung cancer by activating the JAK1/2‐STAT3 pathway［J］. Environ Toxicol， 2023， 38（8）： 1968-1979.
21 XIE X， WANG X， SHI X， et al. Anwulignan is a novel JAK1 inhibitor that suppresses non-small cell lung cancer growth［J］. J Cell Mol Med， 2021， 25（5）： 2645-2654.
22 ZHANG Z， SUN C， ZHENG Y， et al. circFCHO2 promotes gastric cancer progression by activating the JAK1/STAT3 pathway via sponging miR-194-5p［J］. Cell Cycle， 2022， 21（20）： 2145-2164.
Options
Outlines

/

〈 〉